Waters Posts 3 Percent Rise in Q4 Revenues, Plans to Acquire Wyatt Technology for $1.36B
The company said that Wyatt's light scattering and field-flow fractionation tech will help it build out its bioanalytical characterization business.
Berkeley Lights Acquiring IsoPlexis in $57.8M All-Stock Deal
IsoPlexis shareholders will receive 0.612 shares of Berkeley Lights stock for each IsoPlexis share with the combined company taking the name PhenomeX.
ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M
The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets.
SomaLogic Says Palamedrix Technology Could Enable More Accessible, Sensitive Proteomic Assays
The firm aims to release products based on the acquisition in the next few years, such as targeted panels for use in biopharma research or diagnostics.
SomaLogic to Acquire DNA Nanotech Firm Palamedrix for up to $52.5M
SomaLogic said it plans to use Palamedrix's DNA nanotechnology platform to help develop the next generation of its SomaScan proteomic platform.